SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+4.51%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$6.73B
AUM Growth
+$6.73B
(-3.9%)
Cap. Flow
-$357M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
33.82%
Holding
150
New
44
Increased
32
Reduced
19
Closed
45
Top Buys
| 1 |
McDonald's
MCD
|
$214M |
| 2 |
Walt Disney
DIS
|
$212M |
| 3 |
RH
RH
|
$186M |
| 4 |
Paysafe
PSFE
|
$176M |
| 5 |
Mastercard
MA
|
$169M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$237M |
| 2 |
Netflix
NFLX
|
$208M |
| 3 |
Charter Communications
CHTR
|
$190M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$184M |
| 5 |
Fiserv
FI
|
$182M |
Sector Composition
| 1 | Healthcare | 23.7% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Technology | 20.09% |
| 4 | Industrials | 14.35% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BGRY
51
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $25.4M | 0.37% |
+2,500,000
| New | +$25.4M |
|
52
Terns Pharmaceuticals
TERN
$647M
| $24.8M | 0.37% |
+1,125,136
| New | +$24.8M |
|
53
KalVista Pharmaceuticals
KALV
$727M
| $24.7M | 0.36% |
959,892
+650,992
| +211% | +$16.7M |
|
54
Sana Biotechnology
SANA
$729M
| $22.3M | 0.33% |
+667,500
| New | +$22.3M |
|
|
CZOO
55
DELISTED
Cazoo Group Ltd
CZOO
| $22.2M | 0.33% |
+2,165,000
| New | +$22.2M |
|
|
MREO
56
Mereo BioPharma
MREO
$280M
| $21.5M | 0.32% |
6,365,500
+3,616,501
| +132% | +$12.2M |
|
57
Kura Oncology
KURA
$714M
| $20.7M | 0.31% |
732,415
+460,915
| +170% | +$13M |
|
58
Forte Biosciences
FBRX
$137M
| $20.6M | 0.3% |
600,000
+275,000
| +85% | +$9.42M |
|
59
Lyft
LYFT
$7.24B
| $19M | 0.28% |
300,000
-759,660
| -72% | -$48M |
|
60
Fulcrum Therapeutics
FULC
$351M
| $18M | 0.27% |
+1,525,885
| New | +$18M |
|
61
Disc Medicine
IRON
$2.19B
| $17.8M | 0.26% |
+1,312,363
| New | +$17.8M |
|
62
Take-Two Interactive
TTWO
$44.4B
| $15.4M | 0.23% |
87,010
-268,413
| -76% | -$47.4M |
|
|
DCPH
63
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.1M | 0.22% |
+336,808
| New | +$15.1M |
|
|
MILE
64
DELISTED
Metromile, Inc. Common Stock
MILE
| $14.4M | 0.21% |
1,400,010
+250,490
| +22% | +$2.58M |
|
|
SIOX
65
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $14.3M | 0.21% |
+5,489,000
| New | +$14.3M |
|
66
Bolt Biotherapeutics
BOLT
$9.46M
| $13.8M | 0.2% |
+420,365
| New | +$13.8M |
|
67
InflaRx
IFRX
$122M
| $12.8M | 0.19% |
+3,285,000
| New | +$12.8M |
|
68
EyePoint Pharmaceuticals
EYPT
$820M
| $12M | 0.18% |
+1,181,200
| New | +$12M |
|
|
PNT
69
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $11.3M | 0.17% |
+1,076,000
| New | +$11.3M |
|
|
NEXI
70
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $11.1M | 0.16% |
+579,283
| New | +$11.1M |
|
|
FSRXU
71
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
| $10.9M | 0.16% |
+1,092,600
| New | +$10.9M |
|
72
Spyre Therapeutics
SYRE
$1.02B
| $10.8M | 0.16% |
1,367,073
+608,334
| +80% | +$4.82M |
|
|
RXDX
73
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $10.6M | 0.16% |
+578,534
| New | +$10.6M |
|
|
ALUS
74
DELISTED
Alussa Energy Acquisition Corp.
ALUS
| $10M | 0.15% |
+1,000,000
| New | +$10M |
|
|
CMRX
75
DELISTED
Chimerix, Inc.
CMRX
| $8.82M | 0.13% |
+915,264
| New | +$8.82M |
|